LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $236,229,000 | -27.2% | 2,100 | 0.0% | 0.06% | -23.5% |
| Q4 2021 | $324,366,000 | -3.0% | 2,100 | -12.5% | 0.08% | -12.0% |
| Q3 2021 | $334,368,000 | -5.6% | 2,400 | -11.1% | 0.09% | +2.2% |
| Q2 2021 | $354,213,000 | -19.9% | 2,700 | -6.9% | 0.09% | -24.4% |
| Q1 2021 | $442,105,000 | +38.9% | 2,900 | -9.4% | 0.12% | +33.7% |
| Q4 2020 | $318,240,000 | +497.8% | 3,200 | +536.2% | 0.09% | +790.0% |
| Q1 2017 | $53,238,000 | -66.3% | 503 | -67.6% | 0.01% | -66.7% |
| Q4 2016 | $157,800,000 | -66.0% | 1,553 | -65.9% | 0.03% | -63.0% |
| Q3 2016 | $464,679,000 | -32.3% | 4,553 | -20.9% | 0.08% | -31.9% |
| Q2 2016 | $686,160,000 | +13.3% | 5,753 | +1.8% | 0.12% | +6.2% |
| Q1 2016 | $605,380,000 | -30.6% | 5,653 | -29.8% | 0.11% | -25.3% |
| Q4 2015 | $872,781,000 | +4.5% | 8,050 | -17.4% | 0.15% | +37.6% |
| Q3 2015 | $835,088,000 | – | 9,750 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |